Nikolai Petrovsky
Nikolai Petrovsky
Professor of Medicine, Flinders University
Verified email at
Cited by
Cited by
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
TF ADVANCE Collaborative Group, Patel A, MacMahon S
New England Journal of Medicine 358 (24), 2560-72, 2008
The transcriptional landscape of the mammalian genome
P Carninci, T Kasukawa, S Katayama, J Gough, MC Frith, N Maeda, ...
science 309 (5740), 1559-1563, 2005
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
RIKEN Genome Exploration Research Group Phase I Team: Carninci P. 2 Hayatsu ...
Nature 420 (6915), 563-573, 2002
Vaccine adjuvants: current state and future trends
N Petrovsky, JC Aguilar
Immunology and cell biology 82 (5), 488-496, 2004
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line
Nature genetics 41 (5), 553-562, 2009
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications
N Petrovsky, P McNair, LC Harrison
Cytokine 10 (4), 307-312, 1998
Inulin-a versatile polysaccharide with multiple pharmaceutical and food chemical uses.
T Barclay, M Ginic-Markovic, P Cooper, N Petrovsky
Journal of Excipients & Food Chemicals 1 (3), 2010
Technologies for enhanced efficacy of DNA vaccines
F Saade, N Petrovsky
Expert review of vaccines 11 (2), 189-209, 2012
Will blockchain technology revolutionize excipient supply chain management?
S Apte, N Petrovsky
Journal of Excipients and Food Chemicals 7 (3), 76-78, 2016
Molecular mechanisms for enhanced DNA vaccine immunogenicity
L Li, N Petrovsky
Expert review of vaccines 15 (3), 313-329, 2016
Comparative safety of vaccine adjuvants: a summary of current evidence and future needs
N Petrovsky
Drug safety 38 (11), 1059-1074, 2015
The chronobiology of human cytokine production
N Petrovsky, LC Harrison
Cytokines and Cytokine Receptors, 810-824, 2001
Towards a unified model of neuroendocrine–immune interaction
N Petrovsky
Immunology and cell biology 79 (4), 350-357, 2001
Review of polysaccharide particle-based functional drug delivery
TG Barclay, CM Day, N Petrovsky, S Garg
Carbohydrate polymers 221, 94-112, 2019
The future of human DNA vaccines
L Li, F Saade, N Petrovsky
Journal of biotechnology 162 (2-3), 171-182, 2012
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?
N Petrovsky, LC Harrison
Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5163-5168, 1997
Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications
V Brusic, VB Bajic, N Petrovsky
Methods 34 (4), 436-443, 2004
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic …
Y Honda-Okubo, D Barnard, CH Ong, BH Peng, CTK Tseng, N Petrovsky
Journal of virology 89 (6), 2995-3007, 2015
Methods for prediction of peptide binding to MHC molecules: a comparative study
K Yu, N Petrovsky, C Schönbach, JLY Koh, V Brusic
Molecular medicine 8, 137-148, 2002
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Y Honda-Okubo, F Saade, N Petrovsky
Vaccine 30 (36), 5373-5381, 2012
The system can't perform the operation now. Try again later.
Articles 1–20